Betaferon Injection Management: Non-Interventional Study on Personal Digital Assistant (PDA)Supported Effects on Adherence to a Long-Term Injection Therapy (BETAPATH)

Trial Profile

Betaferon Injection Management: Non-Interventional Study on Personal Digital Assistant (PDA)Supported Effects on Adherence to a Long-Term Injection Therapy (BETAPATH)

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Oct 2015

At a glance

  • Drugs Interferon beta-1b (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms BETAPATH
  • Sponsors Bayer
  • Most Recent Events

    • 24 Sep 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Jun 2014 According to the ClinicalTrials.gov record, planned end date changed from 1 May 2014 to 1 Jul 2014.
    • 18 Mar 2014 Planned end date changed from 1 Mar 2014 to 1 May 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top